Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, whi...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
1996-10-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/2/4/96-0411_article |
_version_ | 1811287050343677952 |
---|---|
author | Martin I. Meltzer |
author_facet | Martin I. Meltzer |
author_sort | Martin I. Meltzer |
collection | DOAJ |
description | Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, which can be adapted to different sites, illustrates the use of threshold analysis to link distribution costs, cost savings, bait density, and vaccine price. Initial results indicate the need to lower the cost of the vaccine, continue research to determine optimal bait densities, and examine distribution plans that do not require continued protection of areas in which raccoon rabies was eliminated through previous vaccination programs. |
first_indexed | 2024-04-13T03:11:12Z |
format | Article |
id | doaj.art-5449e361586c4598b389e79ccb045044 |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-04-13T03:11:12Z |
publishDate | 1996-10-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-5449e361586c4598b389e79ccb0450442022-12-22T03:05:03ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60591996-10-012434334910.3201/eid0204.960411Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible ModelMartin I. MeltzerAny cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, which can be adapted to different sites, illustrates the use of threshold analysis to link distribution costs, cost savings, bait density, and vaccine price. Initial results indicate the need to lower the cost of the vaccine, continue research to determine optimal bait densities, and examine distribution plans that do not require continued protection of areas in which raccoon rabies was eliminated through previous vaccination programs.https://wwwnc.cdc.gov/eid/article/2/4/96-0411_articleUnited States |
spellingShingle | Martin I. Meltzer Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model Emerging Infectious Diseases United States |
title | Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model |
title_full | Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model |
title_fullStr | Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model |
title_full_unstemmed | Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model |
title_short | Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model |
title_sort | assessing the costs and benefits of an oral vaccine for raccoon rabies a possible model |
topic | United States |
url | https://wwwnc.cdc.gov/eid/article/2/4/96-0411_article |
work_keys_str_mv | AT martinimeltzer assessingthecostsandbenefitsofanoralvaccineforraccoonrabiesapossiblemodel |